[Drugs for the prevention of death and recurrence after acute myocardial infarction]

[Article in Danish]

Editorial

[Article in Danish]

J F Hansen et al. Ugeskr Laeger. 1992.

. 1992 Feb 10;154(7):397.

No abstract available

Similar articles

[Verapamil therapy improves the prognosis after acute myocardial infarction. A review over the Danish studies of verapamil therapy during and after acute myocardial infarction].
Hansen JF. Hansen JF. Ugeskr Laeger. 1992 Feb 10;154(7):398-404. Ugeskr Laeger. 1992. PMID: 1536049 Review. Danish.
Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction.
Hansen JF. Hansen JF. J Cardiovasc Pharmacol. 1991;18 Suppl 6:S20-5. J Cardiovasc Pharmacol. 1991. PMID: 1725912 Clinical Trial.
A multicenter study on timolol in secondary prevention after myocardial infarction.
[No authors listed] [No authors listed] Acta Med Scand Suppl. 1983;674:1-129. Acta Med Scand Suppl. 1983. PMID: 6580807 Clinical Trial.
[A new indication for verapamil--secondary prevention after myocardial infarction].
Erhardt L. Erhardt L. Lakartidningen. 1992 Jun 24;89(26-27):2340-1. Lakartidningen. 1992. PMID: 1507939 Swedish. No abstract available.
[Secondary prevention after myocardial infarction].
Vacheron A, Bounhoure JP; Groupe de travail de la Commission IV (Maladies cardiovasculaires). Vacheron A, et al. Bull Acad Natl Med. 2007 Nov;191(8):1763-77. Bull Acad Natl Med. 2007. PMID: 18666472 Review. French.